Failure of vitamin E in clinical trials: Is gamma-tocopherol the answer?

Nutrition Reviews

Volumn 63, Issue 8, 2005, Pages 290-293

  Devaraj, Sridevi ^a   Jialal, Ishwarlal ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antioxidant; Inflammation; Nitrative stress; Oxidative stress; Tocopherol

Indexed keywords

ALPHA TOCOPHEROL; GAMMA TOCOPHEROL;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ATHEROSCLEROSIS; BIOAVAILABILITY; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; DIET SUPPLEMENTATION; HUMAN; INFLAMMATION; OXIDATIVE STRESS; SHORT SURVEY; VITAMIN METABOLISM;

ALPHA-TOCOPHEROL; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIOXIDANTS; ARTERIOSCLEROSIS; BIOLOGICAL AVAILABILITY; CARDIOVASCULAR DISEASES; GAMMA-TOCOPHEROL; HUMANS; INTESTINAL ABSORPTION; OXIDATIVE STRESS;

EID: 23844544405     PISSN: 00296643     EISSN: None     Source Type: Journal    
DOI: 10.1301/nr.2005.aug.290-293     Document Type: Short Survey

References (25)

1. Jialal I, Devaraj S. Scientific evidence to support a vitamin E and heart disease health claim: research needs. J Nutr. 2005;135:348-353.
2. Handelman GJ, Machlin LJ, Fitch K, Weiter JJ, Dratz EA. Oral alpha-tocopherol supplements decrease plasma gamma-tocopherol levels in humans. J Nutr. 1985;115:807-813.
3. Traber MG. Vitamin E. In: Shils ME, Olson JA, Shike M, Ross AC, eds. Modern Nutrition in Health and Disease. Baltimore: Williams & Wilkins; 1999;347-362.
4. Wagner KH, Kamal-Eldin A, Elmadfa I. Gammatocopherol: an underestimated vitamin? Ann Nutr Metab. 2004;48:169-188.
5. Devaraj S, Traber MG. 2003. Gamma-tocopherol, the new vitamin E? Am J Clin Nutr. 2003;77:530-531.
6. Friedrich MJ. To "E" or not to "E," vitamin E's role in health and disease is the question. JAMA. 2004; 292:671-673.
7. Traber MG, Arai H. Molecular mechanism of vitamin E transport. Ann Rev Nutr. 1999;19:343-355.
8. Brigelius-Flohe R, Traber MG. Vitamin E: Function and metabolism. FASEB J. 1999;13:1145-1155.
9. Himmelfarb J, McMonagle E. Manifestations of oxidant stress in uremia. Blood Purif. 2001;19:200-205.
10. Jiang Q, Elson-Schwab I, Courtemanche C, Ames BN. γ-tocopherol and its major metabolite, in contrast to α-tocopherol, inhibit cyclooxygenase activity in macrophages and epithelial cells. Proc Natl Acad Sci USA. 2000;97:11494-11499.
11. Hasselwander O, Young IS. Oxidative stress in chronic renal failure. Free Radic Res. 1998;29:1-11.
12. Eisengart A, Milhorat AT, Simon EJ, Sundheim L. The metabolism of vitamin E. II Purification and characterization of urinary metabolites of alpha-to-copherol. J Biol Chem. 1956;221:807-817.
13. Jiang Q, Christen S, Shigenaga MK, Ames BN. γ-tocopherol, the major form of vitamin E in the US diet, deserves more attention. Am J Clin Nutr. 2001; 74:714-722.
14. Cooney RV, Franke AA, Harwood PJ, Hatch-Pigott V, Custer LJ, Mordan LJ. γ-tocopherol detoxification of nitrogen dioxide: superiority to α-tocopherol. Proc Natl Acad Sci USA. 1993;90:1771-1775.
15. Goss SP, Hogg N, Kalyanaraman B. The effect of α-tocopherol on the nitration of γ-tocopherol by peroxynitrite. Arch Biochem Biophys. 1999;363: 333-340.
16. Jiang Q, Ames BN. γ-tocopherol, but not α-tocopherol, decreases proinflammatory eicosanoids and inflammation damage in rats. FASEB J. 2003;17:816-822.
17. Saldeen T, Li D, Mehta JL. Differential effects of α-and γ-tocopherol on low-density lipoprotein oxidation, superoxide activity, platelet aggregation and arterial thrombogenesis. J Am Coll Cardiol. 1999; 34:1208-1215.
18. Liu M, Wallmon A, Olsson-Mortlock C, Wallin R, Saldeen T. Mixed tocopherols inhibit platelet aggregation in humans: potential mechanisms. Am J Clin Nutr. 2003;77:700-706.
19. Albert CM, Gaziano JM, Willett WC, Manson JE. Nut consumption and decreased risk of sudden cardiac death in the Physicians' Health Study. Arch Intern Med. 2002;162:1382-1387.
20. Ohrvall M, Sundlof G, Vessby B. Gamma, but not alpha, tocopherol levels in serum are reduced in coronary heart disease patients. J Intern Med. 1996; 239:111-117.
21. Kontush A, Spranger T, Reich A, Baum K, Beisiegel U. Lipophilic antioxidants in blood plasma as markers of atherosclerosis: the role of alpha-carotene and gamma-tocopherol. Atherosclerosis. 1999;144: 117-122.
22. Kristenson M, Zieden B, Kucinskiene Z, et al. Antioxidant status and mortality from coronary heart disease in Lithuanian and Swedish men: concomitant cross sectional study of men aged 50. BMJ. 1997;314:629-633.
23. Kushi LH, Folsom AR, Prineas RJ, Mink PJ, Wu Y, Bostick RM. Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women. N Engl J Med. 1996;334:1156-1162.
24. Yochum LA, Folsom AR, Kushi LH. Intake of antioxidant vitamins and risk of death from stroke in postmenopausal women. Am J Clin Nutr. 2000;72: 476-483.
25. Himmelfarb J, Kane J, McMonagle E, et al. Alpha and gamma tocopherol metabolism in healthy subjects and patients with end-stage renal disease. Kidney Int. 2003;64:978-991.